SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ampio Pharmaceuticals, Inc. Announces Successful Pre-IND Meeting With the Ophthalmology Division of the FDA on Optina™ for the Treatment of Diabetic Macular Edema